Results 281 to 290 of about 235,642 (386)
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
Nature Genetics, 2016 W. van Rheenen, A. Shatunov, Annelot M. Dekker, R. Mclaughlin, F. Diekstra, S. Pulit, Rick A. A. van der Spek, U. Võsa, S. de Jong, M. Robinson, Jian Yang, I. Fogh, P. T. V. van Doormaal, Gijs H. P. Tazelaar, M. Koppers, A. Blokhuis, W. Sproviero, Ashley R. Jones, K. Kenna, K. van Eijk, O. Harschnitz, Raymond D. Schellevis, W. Brands, J. Medić, A. Menelaou, A. Vajda, N. Ticozzi, Kuang Lin, B. Rogelj, Katarina Vrabec, M. Ravnik-Glavač, B. Koritnik, J. Zidar, L. Leonardis, L. D. Grošelj, S. Millecamps, F. Salachas, V. Meininger, M. de Carvalho, S. Pinto, J. Mora, R. Rojas‐García, M. Polak, S. Chandran, Shuna Colville, R. Swingler, K. Morrison, P. Shaw, J. Hardy, R. Orrell, A. Pittman, K. Sidle, P. Fratta, A. Malaspina, S. Topp, S. Petri, S. Abdulla, C. Drepper, M. Sendtner, T. Meyer, R. Ophoff, K. Staats, M. Wiedau-Pazos, C. lomen-Hoerth, V. V. Van Deerlin, J. Trojanowski, L. Elman, L. McCluskey, A. Başak, Ceren Tunca, Hamid Hamzeiy, Y. Parman, T. Meitinger, P. Lichtner, Milena Radivojkov-Blagojević, C. Andres, Cindy Maurel, G. Bensimon, B. Landwehrmeyer, A. Brice, C. Payan, Safa Saker-Delye, A. Dürr, N. Wood, L. Tittmann, W. Lieb, A. Franke, M. Rietschel, S. Cichon, M. Nöthen, P. Amouyel, C. Tzourio, J. Dartigues, A. Uitterlinden, F. Rivadeneira, K. Estrada, A. Hofman, C. Curtis, H. Blauw, A. J. van der Kooi, M. de Visser, A. Goris, Markus Weber, C. Shaw, Bradley N. Smith, O. Pansarasa, Cristina Cereda, R. del Bo, G. Comi, S. D'alfonso, C. Bertolin, G. Soraru', L. Mazzini, V. Pensato, C. Gellera, C. Tiloca, A. Ratti, A. Calvo, C. Moglia, M. Brunetti, S. Arcuti, R. Capozzo, C. Zecca, C. Lunetta, S. Penco, N. Riva, A. Padovani, M. Filosto, B. Muller, Robbert Jan Stuit, I. Blair, Katharine Y. Zhang, E. McCann, J. Fifita, G. Nicholson, D. Rowe, R. Pamphlett, M. Kiernan, J. Grosskreutz, O. Witte, T. Ringer, T. Prell, B. Stubendorff, I. Kurth, C. Hübner, P. Leigh, F. Casale, A. Chiò, E. Beghi, E. Pupillo, R. Tortelli, G. Logroscino, J. Powell, A. Ludolph, Jochen H Weishaupt, W. Robberecht, P. van Damme, L. Franke, T. Pers, Robert H. Brown, J. Glass, J. Landers, O. Hardiman, P. Andersen, P. Corcia, P. Vourc'h, V. Silani, N. Wray, P. Visscher, P. D. de Bakker, M. V. van Es, R. Pasterkamp, C. Lewis, G. Breen, A. Al-Chalabi, L. H. van den Berg, J. Veldink +176 moresemanticscholar +1 more sourceNanoparticle‐Based Tetracycline Delivery Systems: Advancing Therapeutic Effectiveness and Tackling Antibiotic Resistance
Particle &Particle Systems Characterization, EarlyView.This review explores improved tetracycline (TCN) delivery via polymer‐based nanocarriers to enhance solubility, stability, and targeted release. It also covers stimuli‐responsive systems, triggered by pH, enzymes, or reactive oxygen species (ROS), and co‐delivery approaches that increase therapeutic efficacy in cancer and inflammatory diseases ...Mahsa Molaei Nasr, Mehrab Pourmadadi, Fatemeh Yazdian, Hamid Rashedi, Abbas Rahdar, M. Ali Aboudzadeh +5 morewiley +1 more sourceMathematical Modeling of Neuroinflammation in Neurodegenerative Diseases
CPT: Pharmacometrics &Systems Pharmacology, EarlyView.ABSTRACT
Age‐related neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD) and Parkinson's disease (PD) are an increasing public health concern. Whereas the pathology of these diseases is complex, chronic central inflammation, or neuroinflammation, is commonly observed across many neurodegenerative diseases ...Alex Foster‐Powell, Amin Rostami‐Hodjegan, Guy Meno‐Tetang, Donald E. Mager, Kayode Ogungbenro +4 morewiley +1 more sourceTransforming Pediatric Rare Disease Drug Development: Enhancing Clinical Trials and Regulatory Evidence With Virtual Patients
CPT: Pharmacometrics &Systems Pharmacology, EarlyView.ABSTRACT
Drug development in pediatric rare diseases is complicated by practical and ethical constraints on clinical trial design, stemming from small, highly heterogeneous, and vulnerable patient populations. Virtual patients (VPs) created with machine‐learning (ML), mechanistically driven computational approaches, or hybrids thereof, have the ...Fianne Sips, Marco Virgolin, Giuseppe Pasculli, Federico Reali, Alessio Paris, Annette Janus, Yann Godfrin, Daniel Röshammar, Luca Marchetti, Jane Knöchel +9 morewiley +1 more sourceGenetic Variants Associated With Neurodegenerative Disorders in Patients With Amyotrophic Lateral Sclerosis and Phenotypic Variability. [PDF]
NeurologyGrassano M, Koumantakis E, Palumbo FF, Brunetti M, De Marco G, Merulla I, Paolantonio C, Iazzolino B, Testa M, Manera U, Canosa A, Vasta R, Fuda G, Salamone P, Marchese G, Casale F, Gallone S, Mora G, Moglia C, Calvo A, Chiò A. +20 moreeuropepmc +1 more source